S'abonner

Deficiency of caspase recruitment domain family, member 11 (CARD11), causes profound combined immunodeficiency in human subjects - 30/01/13

Doi : 10.1016/j.jaci.2012.11.050 
Polina Stepensky, MD a, , Baerbel Keller, MSc b, , Mary Buchta b, Anne-Kathrin Kienzler, MSc b, Orly Elpeleg, MD c, Raz Somech, MD, PhD d, Sivan Cohen, MSc e, Idit Shachar, PhD e, Lisa A. Miosge, PhD f, Michael Schlesier, PhD b, g, Ilka Fuchs, MSc b, Anselm Enders, MD h, Hermann Eibel, PhD b, Bodo Grimbacher, MD b, Klaus Warnatz, MD b,
a Pediatric Hematology-Oncology and Bone Marrow Transplantation, Hadassah Hebrew University Medical Center, Jerusalem, Israel 
b Centre of Chronic Immunodeficiency (CCI), University Medical Center Freiburg and University of Freiburg, Freiburg, Germany 
c Monique and Jacques Roboh Department of Genetic Research, Hadassah, Hebrew University Medical Center, Jerusalem, Israel 
d Pediatric Department and Immunology Service, Jeffrey Modell Foundation (JMF) Center, Edmond and Lily Safra Children’s Hospital, Sheba Medical Center, Tel Hashomer, the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel 
e Immunology Department, Weizmann Institute of Science, Rehovot, Israel 
f Department of Immunology, John Curtin School of Medical Research, Australian National University, Canberra, Australia 
g Division of Rheumatology and Clinical Immunology, University Medical Center Freiburg, Freiburg, Germany 
h Ramaciotti Immunization Genomics Laboratory, Department of Immunology, John Curtin School of Medical Research, Australian National University, Canberra, Australia 

Corresponding author: Klaus Warnatz, MD, Centre of Chronic Immunodeficiency, University Medical Center, Freiburg, Breisacher Str. 117, 79106 Freiburg, Germany.

Abstract

Background

Profound combined immunodeficiency can present with normal numbers of T and B cells, and therefore the functional defect of the cellular and humoral immune response is often not recognized until the first severe clinical manifestation. Here we report a patient of consanguineous descent presenting at 13 months of age with hypogammaglobulinemia, Pneumocystis jirovecii pneumonia, and a suggestive family history.

Objective

We sought to identify the genetic alteration in a patient with combined immunodeficiency and characterize human caspase recruitment domain family, member 11 (CARD11), deficiency.

Methods

Molecular, immunologic, and functional assays were performed.

Results

The immunologic characterization revealed only subtle changes in the T-cell and natural killer cell compartment, whereas B-cell differentiation, although normal in number, was distinctively blocked at the transitional stage. Genetic evaluation revealed a homozygous deletion of exon 21 in CARD11 as the underlying defect. This deletion abrogated protein expression and activation of the canonical nuclear factor κB (NF-κB) pathway in lymphocytes after antigen receptor or phorbol 12-myristate 13-acetate stimulation, whereas CD40 signaling in B cells was preserved. The abrogated activation of the canonical NF-κB pathway was associated with severely impaired upregulation of inducible T-cell costimulator, OX40, cytokine production, proliferation of T cells, and B cell–activating factor receptor expression on B cells.

Conclusion

Thus in patients with CARD11 deficiency, the combination of impaired activation and especially upregulation of inducible T-cell costimulator on T cells, together with severely disturbed peripheral B-cell differentiation, apparently leads to a defective T-cell/B-cell cooperation and probably germinal center formation and clinically results in severe immunodeficiency. This report discloses the crucial and nonredundant role of canonical NF-κB activation and specifically CARD11 in the antigen-specific immune response in human subjects.

Le texte complet de cet article est disponible en PDF.

Key words : CARD11, human, combined immunodeficiency, hypogammaglobulinemia, profound combined immunodeficiency disorder, transitional B cell, nuclear factor κB, B cell-activating factor receptor, inducible T-cell costimulator, germinal center

Abbreviations used : APC, BAFF-R, BCL10, BCR, CARD11, CD40L, CID, ERK, FITC, GC, gDNA, ICOS, KREC, MALT1, NF-κB, NK, pCID, PE, PerCP, PMA, TCR, TREC, Treg


Plan


 Supported by Deutsche Forschungsgemeinschaft Grant SFB 620 (to K.W.) and by the Federal Ministry of Education and Research (BMBF 01 EO0803, to K.W., H.E., and B.G.). P.S. was supported by a Dahlia Greidinger Cancer Research Fund. A.E. was supported by a Major Initiative Award from the Clive and Vera Ramaciotti Foundation and a Career Development Fellowship from the NHMRC (APP1035858).
 Disclosure of potential conflict of interest: B. Keller has received grants from Bundesministerium fur Bildung und Forschung (BMBF). B. Grimbacher has received grants from the Federal Ministry of Education and Research. K. Warnatz has received grants from BMBF and Baxter, and has received payment for lectures, including service on speakers’ bureaus, from Baxter, GlaxoSmithKline, CSL Behring, and Pfizer. I. Fuchs has received grants from BMBF. The rest of the authors declare that they have no relevant conflicts of interest.


© 2013  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 131 - N° 2

P. 477 - février 2013 Retour au numéro
Article précédent Article précédent
  • TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes
  • Monica Martinez-Gallo, Lin Radigan, María Belén Almejún, Natalia Martínez-Pomar, Núria Matamoros, Charlotte Cunningham-Rundles
| Article suivant Article suivant
  • Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation
  • Aude Magerus-Chatinet, Marie-Claude Stolzenberg, Nina Lanzarotti, Bénédicte Neven, Cécile Daussy, Capucine Picard, Nathalie Neveux, Mukesh Desai, Meghana Rao, Kanjaksha Ghosh, Manisha Madkaikar, Alain Fischer, Frédéric Rieux-Laucat

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.